Description
This compound may exhibit anti-angiogenic and anticancer benefit through the potential inhibition of VEGFR2 (Flk-1), Met, RET, Axl, Ron, PDGFR, FGFR1 (Flg), and FMS-related tyrosine kinases 1, 3, and 4 (FLT1/3/4).
This compound may exhibit anti-angiogenic and anticancer benefit through the potential inhibition of VEGFR2 (Flk-1), Met, RET, Axl, Ron, PDGFR, FGFR1 (Flg), and FMS-related tyrosine kinases 1, 3, and 4 (FLT1/3/4).
| Cas No. | 13080-85-8 |
|---|---|
| Purity | ≥98% |
| Formula | C24H20N2O2 |
| Formula Wt. | 368.43 |
| IUPAC Name | 4-[4-[4-(4-aminophenoxy)phenyl]phenoxy]aniline |
| Synonym | 4,4’-Bis(4-aminophenoxy)biphenyl |
| Appearance | White to off white powder |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| Info Sheet | B3472 Info Sheet PDF |
|---|